Understanding genetic factors in hereditary diabetes related to the endoplasmic reticulum.
Molecular Genetics of Hereditary Endoplasmic Reticulum Diabetes
This study is looking at how certain genetic differences can impact the health of insulin-producing cells in the pancreas, which could help us find new treatments for diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11086112 on NIH RePORTER |
What this research studies
This research investigates how genetic variations affect the function of the endoplasmic reticulum (ER) in pancreatic beta cells, which are crucial for insulin production. By examining specific gene variants associated with hereditary forms of diabetes, the study aims to uncover the mechanisms leading to beta cell dysfunction and death. The approach includes functional assays and bioinformatics to identify potential treatments that target the pathways disrupted in these cells. Patients may benefit from insights that could lead to novel therapies for diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with hereditary forms of diabetes, particularly those with known genetic variants affecting beta cell function.
Not a fit: Patients without hereditary diabetes or those whose diabetes is not linked to the genetic variants being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the health and management of diabetes for patients with specific genetic backgrounds.
How similar studies have performed: Previous research has shown promise in understanding the role of the endoplasmic reticulum in diabetes, suggesting that this approach could yield valuable insights.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Urano, Fumihiko — Washington University
- Study coordinator: Urano, Fumihiko
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.